Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues greater than $30 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in New York City.
Join Mergr to view the latest updates and news from Accelmed.
Accelmed’s most common sector for investment is software (100%). The Firm’s most common investment types include secondary buyout (100%). In total, Accelmed has invested in 1 US state.
Join Mergr to view Accelmed’s full profile and discover more small private equity firms just like it.
No obligation. Cancel anytime.